Combination of dabrafenib (DAB).

已取消 10 由 upupup 发布于 2024/3/2 23:43:02

DOI:10.1200/jco.2017.35.15_suppl.6085
作者： Eric Jeffrey Sherman, Alan Loh Ho, Shrujal S. Baxi, Lara Dunn, Susan H. Korte, Sofia Haque, Ronald A. Ghossein, Helen X. Chen
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1200/JCO.2017.35.15_SUPPL.6085

American Society of Clinical Oncology (ASCO)

Abstract：6085Background: BRAFV600E mutations (BRAFm) are the most common mutations in thyroid cancer. BRAF inhibitors are active in BRAFm melanoma, but there is less activity noted in BRAFm thyroid c

应助信息

2024-03-02

Book学术机器人

2024/3/2 23:43:03 未找到该文献，机器人已退出，请等待人工下载

2024/3/2 23:43:02 Book学术AI机器人收到请求，开始寻找文献

2024/3/2 23:43:02 已向机器人发送请求

2024-03-02

upupup 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Institute of Electrical and Electronics Engineers (IEEE)Quo Vadis Sustainable Entrepreneurship? A Systematic Literature Review of Related Drivers and Inhibitors in SMEs